Latest Conference Articles

What are the latest drugs available in primary care and what role do they play in pharmacy practice?

Ethical dilemmas do surface from time to time in the pharmacy.

At the ASHP 2017 Summer Meeting and Exhibition held in Minneapolis, Minnesota, several speakers spoke about the misuse and abuse of opioids. In this clip, Tim Stratton, PhD, BCPS, FAPhA, Professor of Pharmacy Practice at the University of Minnesota, discusses the ethical dimensions of the opioid crisis from a pharmacy practice and public health perspective.

Here are some sessions to watch for in our coverage at this year’s meeting.

Pediatric patients can benefit from improved discharge medication services when transitioning from hospital to home, according to data reported in a poster presentation at the American Pharmacists Association (APhA) 2017 Annual Meeting & Exposition.

Community pharmacists can play a valuable role in preventing hospital readmissions through patient education and resolution of identified drug therapy problems, according to data reported in a poster presentation at the American Pharmacists Association (APhA) 2017 Annual Meeting & Exposition in San Francisco.

Consumers feeling overloaded by DTC pharmaceutical ads.

Thanks for following us on Twitter, Instagram, and Facebook!

In this clip taken at APhA 2017, Evan Sisson, PharmD, of VCU School of Pharmacy discusses the role of the pharmacist in counseling patients about cardiovascular medication and nutraceutical use.

Adults who receive vaccination reimbursement through an employer-sponsored pharmacy insurance benefit may be more likely to receive vaccinations, according to data revealed in a poster presentation at the American Pharmacists Association (APhA) 2017 Annual Meeting & Exposition in San Francisco.

Advocacy, patient feedback encouraged during APhA keynote address.

Public perceptions on naloxone may differ by community.

At the American Pharmacists Association 2017 meeting, an inspiring and practical session titled “Leading by Example” showed how pharmacists can leverage their value to establish health care team partnerships (eg, with health systems and physician practices) and implement programs to win pharmacy “champions,” improve patient outcomes, and reduce health care costs.

Pharmacists play an important role in helping to deal with clinical inertia.

There are several new options coming down the pipeline for patients with type 2 diabetes.

Continuing education remains an important part of a pharmacist's life, particularly those dealing with an ever-increasing population of patients with diabetes.

There are several new treatments in the pipeline that hold promise for patients with type 2 diabetes.

Sessions focuses on new diabetes treatment options.

Two new fixed-dose basal/GLP-1 receptor-agonist agents, Soliqua 100/33 (Sanofi) and Xultophy 100/3.6 (Novo Nordisk), were approved by the FDA in November 2016.

In this clip, Jeffrey Fudin, PharmD, who spoke at APHA 2017 on opioid tapering, discusses options pharmacists should consider when tapering patients.

In this clip, Jeffrey Fudin, PharmD, discusses available options in abuse-deterrent formulations of opioids.

APhA is about to kick off and we'll be there all weekend covering it live!

At the American College of Cardiology Scientific Session, a study of prescriptions for PCSK9 inhibitors confirms what doctors say about trying to get their patients access to the cholesterol drug.

A double dose of inclisiran reduced LDL cholesterol up to 52.6%.

Discrepancies found when comparing real-world findings to clinical trial findings.

Preliminary trial finds moderate-intensity exercise does not increase adverse events in this patient population.

Researchers sought to change the volume of fatty deposits in a coronary artery that was at least 30% blocked.

Study compares common treatment options to prevent recurrent venous thromboembolism.

Complications associated with left main bifurcation can impact stent choice.